Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Engrailed 1 shapes the dopaminergic and serotonergic landscape through proper isthmic organizer maintenance and function.

Kouwenhoven WM, Veenvliet JV, van Hooft JA, van der Heide LP, Smidt MP.

Biol Open. 2016 Feb 15;5(3):279-88. doi: 10.1242/bio.015032.

2.

Studying Mesodiencephalic Dopaminergic Neuron Development In Vivo to Improve Stem Cell Therapy in Parkinson's Disease.

Veenvliet JV.

J Neurosci. 2016 Feb 10;36(6):1794-6. doi: 10.1523/JNEUROSCI.4285-15.2016. No abstract available.

3.

Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Veenvliet JV, Smidt MP.

Cell Mol Life Sci. 2014 Dec;71(24):4703-27. doi: 10.1007/s00018-014-1681-5. Epub 2014 Jul 27. Review.

PMID:
25064061
4.

Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons.

Roessler R, Smallwood SA, Veenvliet JV, Pechlivanoglou P, Peng SP, Chakrabarty K, Groot-Koerkamp MJ, Pasterkamp RJ, Wesseling E, Kelsey G, Boddeke E, Smidt MP, Copray S.

Stem Cell Reports. 2014 Apr 3;2(4):520-33. doi: 10.1016/j.stemcr.2014.03.001. eCollection 2014 Apr 8.

5.

A solution to dependency: using multilevel analysis to accommodate nested data.

Aarts E, Verhage M, Veenvliet JV, Dolan CV, van der Sluis S.

Nat Neurosci. 2014 Apr;17(4):491-6. doi: 10.1038/nn.3648. Epub 2014 Mar 26.

PMID:
24671065
6.

Lmx1a encodes a rostral set of mesodiencephalic dopaminergic neurons marked by the Wnt/B-catenin signaling activator R-spondin 2.

Hoekstra EJ, von Oerthel L, van der Heide LP, Kouwenhoven WM, Veenvliet JV, Wever I, Jin YR, Yoon JK, van der Linden AJ, Holstege FC, Groot Koerkamp MJ, Smidt MP.

PLoS One. 2013 Sep 16;8(9):e74049. doi: 10.1371/journal.pone.0074049. eCollection 2013.

7.

Specification of dopaminergic subsets involves interplay of En1 and Pitx3.

Veenvliet JV, Dos Santos MT, Kouwenhoven WM, von Oerthel L, Lim JL, van der Linden AJ, Koerkamp MJ, Holstege FC, Smidt MP.

Development. 2013 Aug;140(16):3373-84. doi: 10.1242/dev.094565. Epub 2013 Jul 17. Erratum in: Development. 2013 Oct;140(19):4116.

8.

Epigenetic mechanisms in the development and maintenance of dopaminergic neurons.

van Heesbeen HJ, Mesman S, Veenvliet JV, Smidt MP.

Development. 2013 Mar;140(6):1159-69. doi: 10.1242/dev.089359. Review.

9.

S-nitrosylation of HDAC2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration.

Nott A, Nitarska J, Veenvliet JV, Schacke S, Derijck AA, Sirko P, Muchardt C, Pasterkamp RJ, Smidt MP, Riccio A.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3113-8. doi: 10.1073/pnas.1218126110. Epub 2013 Jan 28.

10.

Retinoic acid-dependent and -independent gene-regulatory pathways of Pitx3 in meso-diencephalic dopaminergic neurons.

Jacobs FM, Veenvliet JV, Almirza WH, Hoekstra EJ, von Oerthel L, van der Linden AJ, Neijts R, Koerkamp MG, van Leenen D, Holstege FC, Burbach JP, Smidt MP.

Development. 2011 Dec;138(23):5213-22. doi: 10.1242/dev.071704.

11.

Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.

Verheij MM, Veenvliet JV, Groot Kormelink T, Steenhof M, Cools AR.

Psychopharmacology (Berl). 2009 Aug;205(3):441-55. doi: 10.1007/s00213-009-1552-1. Epub 2009 May 12.

Supplemental Content

Loading ...
Support Center